Ultragenyx Pharmaceutical Inc. (RARE) Earnings
|
Expand Research on RARE
| Next EPS Date | 5/2/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -1.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/15/24 | Q423 | -$1.52 | -$1.70 | +$0.18 | $127.39M | $119.38M | N/A |  | | Details | |
| 5/2/24 | Q124 | N/A | -$1.76 | N/A | N/A | $116.23M | N/A | N/A | N/A | ||
| 11/2/23 | Q323 | -$2.23 | -$2.07 | -$0.16 | $98.1M | $109.79M | N/A | | | Details | |
| 8/3/23 | Q223 | -$2.25 | -$2.09 | -$0.16 | $108.3M | $107.1M | N/A | | | Details | |
| 5/8/23 | Q123 | N/A | -$1.97 | N/A | N/A | $104.74M | N/A | N/A | N/A | ||
| 2/16/23 | Q422 | -$2.16 | -$2.14 | -$0.02 | $103.35M | $101.94M | N/A | | | Details | |
| 11/2/22 | Q322 | -$1.08 | -$1.30 | +$0.22 | $81.65M | $96.08M | N/A | | | Details | |
| 7/28/22 | Q222 | -$2.26 | -$1.75 | -$0.51 | $89.3M | $87.65M | N/A | | | Details |
